ARS Pharmaceuticals, Inc.
← Back to SPRY Overview

ARS Pharmaceuticals, Inc. (SPRY)

Profitability & Net Margin History

Current Net Margin

-147.13%

ARS Pharmaceuticals, Inc. currently has a net profit margin of -147.13%.

Financial Fundamentals

SPRYQuarterly Data • 5Y View

Historical Margin Data

DateRev ($B)NI ($B)Net MarginChange (bps)
2025-12-310.03-0.04-147.13%1025
2025-09-300.03-0.05-157.38%12819
2025-06-300.02-0.04-285.57%14012
2025-03-310.01-0.03-425.69%48336
2024-12-310.090.0557.67%98262
2024-09-300.00-0.02-924.95%157825
2024-06-300.00-0.01-2503.20%
2024-03-310.00-0.01
2023-12-310.00-0.01
2023-09-300.00-0.01
2023-06-300.00-0.02-173700.00%9889500
2023-03-310.00-0.01-74805.00%
2022-12-310.00-0.01
2022-09-300.00-0.01-3483.07%209945
2022-06-300.00-0.01-1383.62%29011
2022-03-310.00-0.01-1093.51%41182
2021-12-310.00-0.01-681.70%41868
2021-09-300.00-0.01-1100.38%88037
2021-06-300.00-0.00-220.00%0
2021-03-310.00-0.00-220.00%
2020-12-310.00-0.01
2020-06-300.00-0.01
2020-03-310.00-0.01
2019-12-310.00-0.01

* Basis Point (bps) change measures sequential efficiency shifts. 100 bps = 1.00% Margin change.